ABSTRACT β-galactomannans found in soy-based broiler feed are known to cause physiological effects that are hypothesized to be related to gut inflammation. Previous studies have shown that the incorporation of β-mannanase in the diet or as a supplement results in improvements to certain performance parameters related to gut health and feed conversion. Using kinome analysis, we characterized the mechanism of β-galactomannan activity and supplementation with β-mannanase on the gut of commercial broilers to understand the mode of action. Two doses of β-mannanase (200 and 400 g/ton of feed) with and without inclusion of additional β-galactomannan (3,000 ppm) were tested at 3 time points (d 14, d 28, and d 42 post hatch). Broilers were fed starter (d 0 to 14), grower (d 15 to 28), and finisher diets (d 29 to 42). Jejuna were collected from birds from each treatment condition and time point. Cluster analysis of the kinome data showed that birds clustered first by age, then predominantly by whether β-mannanase had been included in the diet. Biological pathway analysis showed that the inclusion of additional β-galactomannan into the diet resulted in increased signaling related to immune response, relative to our normal control diet (with reduced soybean meal). The addition of β-mannanase to the enhanced β-galactomannan diet eliminated the majority of this immune-related signaling, indicating that the feed-induced immune response within the jejuna had been eliminated by the addition of β-mannanase. We also saw changes in specific metabolic and gut function pathways in birds fed β-mannanase. These observed changes in β-mannanase-fed birds are likely the mechanism for the enhanced performance and feed conversion observed in birds given β-mannanase in their diets.
INTRODUCTION
Certain ingredients used in standard US commercial broiler diets contain dietary non-starch polysaccharides (NSP). Dietary NSP are indigestible by poultry, however, represent a potential energy source that can be utilized with the proper addition of exogenous enzymes (Meng et al., 2005) . Soybean meal (SBM) is a primary source of vegetable protein that contains 3% soluble NSP and 16% insoluble NSP (Irish and Balnave, 1993) , consisting mainly of mannans and galactomannans (Slominski, 2011) . Beta-mannan (β-mannan), also referred to as beta-galactomannan (βGAL), is a polysaccharide that has repeating units of mannose containing galactose and/or glucose (Carpita and McCann, 2000; Hsiao et al., 2006) . βGAL content in dehulled SBM has been reported at levels from 1.02 to 1.51% (Hsiao C et al., 2006) . Although βGAL content of SBM is in relatively low concentrations, it is a concern for nutritionists due to the presence of anti-nutritive properties. Mannans comprise surface components of multiple pathogens that the innate immune system recognizes. Their presence in diets can stimulate the innate immune system, leading to a purposeless energy-draining immune response (Hsiao et al., 2006) . Inclusion of exogenous enzymes could be a viable option to mitigate these negative impacts of βGAL in diets containing soybean meal.
Specifically, β-mannanase targets βGAL that is present in the diet. Inclusion of β-mannanase in broiler diets has shown to increase apparent metabolized energy corrected for nitrogen (AMEn) and body weight gain and improve feed conversion ratio (Daskiran et al., 2004; Jackson et al., 2004; Lee et al., 2005; Zangiabadi and Torki, 2010) . Basal diets in this study were formulated with minimal SBM inclusion, and dietary guar gum was included at varying levels to increase levels of βGAL across treatments. Guar gum galactomannan has a similar galactose:mannose ratio to SBM with a 4307 0.1% difference (Whistler and Smart, 1953; Whistler and Saarnio, 1957; Hsiao et al., 2006) . The guar gum used in the current trial had a galactomannan concentration of 70% and was included to increase the level of βGAL substrate. Immunological benefits have been reported with the inclusion of β-mannanase, such as reductions in lesion development observed in broilers subjected to a necrotic enteritis model through a combined Eimeria species and Clostridium perfringens challenge (Jackson et al., 2003) . Additional benefits have been attributed to the reduction of viscous material in diets with elevated galactomannan contents (Lee et al., 2003) . β-mannanase inclusion also has shown to increase average body weight and reduce FCR in broilers fed a reduced energy diet (Williams et al., 2014) .
Benefits from β-mannanase inclusion in broiler diets have been well documented (Jackson et al., 2003 , Lee et al., 2003 Daskiran et al., 2004; Jackson et al., 2004; Lee et al., 2005; Zangiabadi and Torki, 2010) . However, the understanding of the physiological effects of βGALs on the gut of broilers, aside from the hypothesized interaction with mannan receptors and β-mannanase's reduction in the supposed feed-induced gut inflammation, has been limited to date. A detailed characterization βGAL's effects on the broiler gut and how these effects are mitigated by β-mannanase has been difficult due to the paucity of molecular/proteomic tools available. Our group has pioneered the use of kinomics to study the physiology of poultry gut in a variety of biological contexts (Arsenault et al., 2013 (Arsenault et al., , 2016 Kogut and Arsenault, 2015) . Intracellular signal transduction mediated by protein phosphorylation controls nearly every cell and tissue response in vertebrates. Biological processes such as inflammation, immunity, metabolism, and cellular response to stress can be crucial to understanding phenotypic changes in the gut. Without a mechanistic understanding of how feed additives impact the gut response, either positively or negatively, it is difficult to make informed management decisions such as dose, duration, when to supplement and when not to, or what combination of additives would create positive or negative additive/synergistic effects. Here we have applied the chicken-specific immunometabolic kinome peptide array to study the cellular signaling changes in broiler chicken jejuna due to βGAL and β-mannanase. We confirm at a proteomic, post-translational level what has been hypothesized previously: that βGAL is an inducer of gut inflammation and that the addition of β-mannanase to feed can reduce this effect. We also have observed evidence that β-mannanase may have additional positive metabolic effects on the broiler gut beyond being anti-inflammatory and energy sparing.
MATERIALS AND METHODS

Experimental Design
The effect of β-mannanase (Hemicell R -HT, Elanco Animal Health, Greenfield, IN) inclusion on broiler jejuna kinome response when administered in the presence or absence of additional dietary βGAL was evaluated in a completely randomized block design during a 42 d grow-out. The experimental design consisted of 3 β-mannanase 1 concentrations (0, 200, or 400 g/ton) with or and without additional dietary βGAL 2 (3,000 ppm) from dietary guar gum. Guar gum galactomannan has a similar galactose:mannose ratio to SBM with a 0.1% difference [Whistler and Smart, 1953; Whistler and Saarnio, 1957; Hsiao et al., 2006] . The guar gum used in the current trial had a galactomannan concentration of 70% and was included to increase the level of β-mannan substrate. These groups yielded a total of 6 treatments.
Experimental Diets
Diets were corn and soybean meal based and formulated in an effort to reduce soybean meal to ultimately decrease the amount of βGAL content in the control diet (Table 1) . Therefore, corn gluten, distillers dried grains with solubles (DDGS), and meat and bone meal (MBM) were included in the diet as alternative protein sources. The analyzed nutrient content for crude protein was 22.50% for the starter, 20.10% for the grower, and 18.84% for the finisher. For each feeding phase, a large control diet was manufactured and split into 9 equal treatments. Treatments consisted of β-mannanase at 0, 200, or 400 g/ton and βGAL at 0 or 3,000 ppm. Sand was used as a filler to ensure all inclusions were equal. Pelleting temperatures were maintained between 74
• and 76 • C. Lower pelleting temperatures were targeted to ensure maximum level of enzyme recovery was achieved. All diets were pelleted with the exception of the starter diet, which was pelleted and then crumbled. The starter diet was fed from d 0 to 14, grower from d 15 to 28, and finisher from d 29 to 42. Nutrient analysis and enzyme activity in the finished feed was analyzed and verified by the manufacturer.
Animals and Management Practice
On d of hatch, 3,132 male broiler chicks were randomly allotted to floor pens and dietary treatments based on initial body weight. The study consisted of 108 total pens with 12 blocks of 9 contiguous pens, each containing 29 chicks at one d of age. 
Peptide Array Experimental Protocol
Jejuna tissue samples were removed from 5 chickens per treatment group at each d of collection (d 14, 28, and 42 post hatch), placed in 1.8 mL cryovials, and immediately flash frozen in liquid nitrogen to preserve kinase enzymatic activity. Samples were taken from liquid nitrogen and transferred to a −80
• C freezer until further experimental procedures were conducted.
Tissue samples were thawed, and a 40 mg section was collected and placed in 2.0 mL homogenizer tubes containing 1.5 mm Zirconium beads (Bioexpress, Kaysville, UT) and 100 uL of lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM Na3VO4, 1 mM NaF,1 ug/mL leupeptin, 1 g/mL aprotinin, and 1 mM phenylmethylsulfonyl fluoride [PMSF] ) (all products from Sigma-Aldrich, St. Louis, MO, unless indicated).
Samples were homogenized by a Bead Bug Microtube Homogenizer (Benchmark Scientific, Edison, NJ) run at 4,000 rpm for 30 seconds.
Homogenized tissue was incubated on ice for 10 min then spun in a microcentrifuge at 14,000 g for 10 min at 4
• C. A 70 uL aliquot of the resultant supernatant was mixed with 10 uL of activation mix (50% glycerol, 500 uM ATP [New England BioLabs, Ipswich, MA], 60 mM MgCl2, 0.05% [vol/vol] Brij 35, 0.25 mg/mL bovine serum albumin [BSA] ) in a new microcentrifuge tube. Peptide array production was done on a contract basis with JPT Peptide Technologies (Berlin, Germany). 771 unique kinase substrate target peptide sequences were printed in replicate 9 times.
A 25 × 60 mm, 85 uL glass lifter slip was applied to the microarray to sandwich and disperse the applied lysate. Eighty μL of the mixture were applied to the peptide microarray, ensuring that no bubbles were present in the pipette tip or array slide. Slides were incubated for 2 h in a humidity chamber: a sealed container containing a small amount of water (not in contact with the arrays) within an incubator at 37
• C at 5% CO 2 . Arrays were removed from the incubator and humidity chamber and placed in a 50 mL centrifuge tube containing phosphate-buffered saline (PBS)-1% Triton. The arrays were submerged repeatedly until the lifter slip slid off the array. Arrays were then submerged in 2 M NaCl-1% Triton and agitated for a minimum of 10 seconds. This process was then repeated with fresh 2 M NaCl-1% Triton. Arrays were submerged in ddH20 and agitated for a minimum of 10 seconds. Array slides were removed from the ddH20 and submerged in phospho-specific fluorescent ProQ Diamond Phosphoprotein Stain (Life Technologies, Carlsbad, CA) in a dish and placed on a shaker table at 50 rpm for one h. The dish was covered to protect the fluorescent stain from light. Arrays were then placed in a new dish and submerged in destaining solution containing 20% acetonitrile (EMD Millipore Chemicals, Billerica, MA) and 50 mM sodium acetate (Sigma) at pH 4.0 for 10 min with agitation at 50 rpm. The petri dish was covered to protect the stain from light. This process was repeated 2 times. A final wash was done with distilled deionized H2O.
Arrays were placed in 50 mL centrifuge tubes with a crumpled kim wipe in the bottom. The tubes containing the arrays were then centrifuged at 300 x g for 2 min to remove any moisture from the array. Arrays were scanned using a Tecan PowerScanner microarray scanner (Tecan Systems, San Jose, CA) at 532 to 560 nm with a 580-nm filter to detect dye fluorescence.
Statistical and Data Analysis
Images were generated, and the spot intensity signal was collected as the mean of pixel intensity using local feature background intensity calculation with the default scanner saturation level.
Images were gridded using GenePix Pro 6.0 software (Molecular Devices, Sunnyvale, CA), and the spot intensity signal was collected as the mean of pixel intensity using local feature background intensity calculation with the default scanner saturation level. The resultant data were then analyzed by the PIIKA2 peptide array analysis software (Trost et al., 2013, p. 2) . Briefly, the resulting data points were normalized to eliminate variance due to technical variation, e.g., random variation in staining intensity between arrays or between array blocks within an array. Variance stabilization normalization was performed. Note: As the arrays were printed with triplicate peptide blocks, there were 3 values for each peptide. Using the normalized data set, comparisons between treatment and control groups were performed, calculating fold change and a significance P-value. The P-value is calculated by conducting a one-sided paired t test between treatment and negative control values for a given peptide. The resultant fold change and significance values were then used to generate optional analysis (heatmaps, hierarchical clustering, principal component analysis, and pathway analysis).
RESULTS
Treatment Clustering
Two doses of β-mannanase (200 and 400 g/ton of feed) with and without inclusion of additional βGAL (3,000 ppm) were tested at 3 time points (d 14, d 28, and d 42 post hatch). It is important to note that all of the data were generated relative to negative control birds that received a normal diet (no β-mannanase or additional βGAL). Figure 1 shows a heatmap of the complete kinome dataset collected. Each column displays jejuna phosphorylation signals from an experimental condition. The red and green represent a relative increased or decreased peptide phosphorylation signal, respectively. The connecting lines above the heatmap represent the clustering based on relative similarity between the experimental conditions (as described on the X-axis). Patterns of phosphorylation signal (red and green) for a given condition are referred to as its kinotype, akin to a phenotype but referring to complete kinome data profiles. The heatmap illustrates how the clusters are generated; the more similar the red and green phosphorylation pattern of each treatment (column), the closer they cluster. It can be observed in Figure 1 that the kinotypes clustered first, based on the d post hatch, as all samples from a given d are associated most closely with each other (see X-axis label of the d post hatch).
There is a significant amount of information that can be mined from the cluster analysis of the kinotypes. To simplify the visualization of the data, Figure 2 shows only the clustering of treatment kinotypes, relative to control, without the phosphorylation signal heatmap. The clustering figure has been rotated to enhance the ease of reading the treatment conditions. To simplify further, let us consider each d one at a time. In Figure 2 , starting with d 14, it can be observed that the samples from birds given feed containing β-mannanase, regardless of whether they were given an additional dose of βGAL at 3,000 ppm, cluster together. The orange boxes highlight these 2 clusters: birds given 400 g/ton β-mannanase with or without 3,000 ppm βGAL cluster, as do birds given 200 g/ton β-mannanase with or without 3,000 ppm βGAL. This result indicates that β-mannanase was having a similar effect on the broiler jejunum, regardless of βGAL levels, likely counteracting both the endogenous βGAL in the soy-based diet and the additional βGAL added. Now considering the d 28 cluster from Figure 2 , more separation of the different treatment groups is observed. There was only one paired cluster, shown in the red box: β-mannanase supplemented in feed at 200 g/ton with additional βGAL at 3,000 ppm clusters with β-mannanase at 400 g/ton.
Finally, consider the treatment groups from d 42 in Figure 2 . Again, there is a cluster of kinotypes in the jejunum of birds supplemented with β-mannanase, regardless of whether or not they were given additional βGAL (shown in the green box). The outlier among this trend was the β-mannanase 200 g/ton, which did not cluster with the other β-mannanase-supplemented groups. From the data presented, the addition of βGAL and of β-mannanase to feed had measureable effects on the jejuna kinome profile of broiler chickens as represented by the cluster analysis. The following section describes in more detail the biological responses that make up the distinct effects βGAL and β-mannanase had on the broiler gut.
Biological Responses
The next step in the data analysis was to consider what specific biological effects these phosphorylation changes represented. Table 2 shows biological processes that were changed in the jejunum by the addition of βGAL, and the addition of βGAL plus 400 g/ton β-mannanase, to the feed of birds across all 3 d tested. There were a number of immune response processes altered with the addition of βGAL to the feed (shown in bold). The activation of these immune response pathways was likely a result of immune receptor stimulation by the addition of 3,000 ppm βGAL to the diet, as compared to control fed birds. As this analysis was a direct comparison of jejuna response in birds given additional βGAL to those given a normal diet, the only variable was the additional βGAL. The additional βGAL was inducing broad-spectrum, feed-induced immune response that was appearing in the kinome analysis.
Pathways that were altered when birds were fed βGAL and β-mannanase also are shown in Table 2 . For this analysis, responses across all 3 d for the (2002), (Shimodaira, 2004) , while the green numbers represent the standard bootstrap P-value (Felenstein, 1985) . All calculations and the drawing of the figure were performed using the R package pvclust (Suzuki and Shimodaira, 2006) . 400 g/ton high dose of β-mannanase were used, as the high dose elicited the most distinct response to the enzyme (Figures 1 and 2) . The most obvious difference upon the addition of β-mannanase was a significant reduction in immune-related pathways (only a few pathways related to specific pathogens were present). This result was especially apparent looking at the most significant results for each treatment condition. With βGAL addition, the top 2 responses relate to immune response and regulation, and with the addition of β-mannanase, the top responses relate to growth and metabolism "pathways in cancer" (includes a number of growth factors, as they are also potential oncogenes) and "insulin signaling pathway." There were a number of metabolic/growth processes, as well as 2 gut integrity-related processes (tight junction and adherens junction), that were significantly altered by the addition of β-mannanase. β-mannanase was having an effect on carbohydrate metabolism (insulin signaling), growth (ErbB pathway), adipose responses (adipocytokine signaling), and protein metabolism (mTOR pathway). It may be speculated from these responses that β-mannanase is not only reducing the feed-induced immune responses elicited by βGAL, but also improving digestion and gut barrier function over the control standard diet fed birds. Figure 3A shows peptides that displayed significant, unique, and consistent responses to β-mannanase, regardless of the inclusion of additional βGAL, at d 14. Figure 3B shows these results at d 28, and Figure 3C at d 42. The descriptions of these peptides and their phosphorylation state can be found in the Supplementary Data Tables 1 to 3. These data represent the unique β-mannanase pathway, or biomarkers of β-mannanase response, at each day. Despite changes in 1) dose of β-mannanase, 2) the addition or not of βGAL, and 3) the age of the bird, the β-mannanase caused a significant and consistent change in phosphorylation of these peptides. The network diagrams in Figure 3 show that the majority of peptides within these "β-mannanase pathways" are known to interact with each other, as evidenced by the edge lines in the figure connecting the proteins. These interactions indicate that the changes in phosphorylation of these peptides were having a specific, related response, not altering a series of unrelated signaling proteins.
The results show that β-mannanase reduced the βGAL-induced immune response in the chicken jejunum (Table 2) . Also, β-mannanase elicited certain common phosphorylation changes, regardless of whether it was given at 200 or 400 g/ton with or without the addition of βGAL on the 3 d assayed (Figure 3) . Next it was considered whether β-mannanase changes the phosphorylation status of any peptides in the same direction (phosphorylation or dephosphorylation relative to control birds) regardless of dose, addition of βGAL, or age of the bird. Table 3 lists these consistent peptides, which can be considered consistent biomarkers of β-mannanase activity across time. Interestingly, all are dephosphorylated relative to control birds under all β-mannanase treatment conditions at all bird ages. 
DISCUSSION
As reported previously (Arsenault et al., 2014) , our group has developed a unique, species-specific tool for the study of immunometabolism in chicken. This tool is readily expandable to other species and can be used to study of wide variety of biological, metabolic, immunological, and infectious disease questions. Kinomics has been applied to study the physiology of poultry gut in a variety of biological contexts (Arsenault et al., 2013 (Arsenault et al., , 2016 Kogut and Arsenault, 2015) . With the central role of protein phosphorylation mediated intracellular signal transduction in controlling cell and tissue function, kinomics can illuminate mechanism of response in feed-based trials such as this one. Without a mechanistic understanding of how feed additives impact the gut response, either positively or negatively, we are left with an incomplete understanding of how our feed and nutritional interventions truly impact animal health and performance. Figure 1 shows that the kinotypes cluster first based on the d post hatch. Thus, one can easily separate younger birds from the older birds by their kinome profile; at each age, the birds had a discernable kinotype. In addition, it should be noted that at each time point of jejuna sample collection, the birds had been under a different feed regime for approximately 2 wk (starter to grower to finisher), thus these kinotype differences also may be due to feed changes in combination with age. The clustering analysis of the full kinome dataset (Figure 2) showed that the addition of βGAL resulted in a distinct kinome profile, or kinotype, at d 14 and d 28. At each of those d, the additional βGAL kinotype clustered separately from all other treatment conditions due to the effect of βGAL on the gut tissue of these birds. At d 14, the samples from birds given β-mannanase at both doses (200 and 400 g/ton) clustered with the samples from birds given the same dose of β-mannanase, as well as βGAL. This result showed that there was relatively minimal difference in kinotype between these pairs; the β-mannanase is negating the effect of the βGAL. At d 28, there was a similar clustering trend as at d 14; however, the doses cluster differently. The trend was that β-mannanase seemed to be negating the effect of the βGAL. At d 42, as with d 28, 200 g/ton β-mannanase did not cluster with the other β-mannanase groups. The remaining β-mannanase groups clustered together as would be expected from the other days' results. Perhaps at this low dose (200 g/ton) in the older birds, β-mannanase alone was not eliciting as strong a physiological response, and it was not able to override the feed-induced response elicited by the βGAL. It may be that the higher dose of β-mannanase is required in the older birds to generate the strong consistent responses observed earlier. These results may indicate that a lower dose of β-mannanase is effective early, but the dose should be increased during later grow-out in the finisher feed.
It has been postulated previously by other groups that the presence of βGAL in the chicken diet can result in an immune response (Haiao et al., 2006) . We observed a clear feed-induced immune response (FIIR) due to feed supplementation with βGAL. Considering the results in Table 2 , we saw that βGAL induce a type of FIIR, as evidenced by the immune response changes, and upon the addition of β-mannanase, this FIIR was eliminated and replaced by changes in a number of cell growth, metabolism, and cell-cell interaction responses. With the addition of β-mannanase, many of the immune response signals were no longer present. There were a number of metabolic/growth processes (insulin signaling, ErbB pathway, adipocytokine signaling, and mTOR pathway) as well as two cell-cell interaction/gut integrity-related pathways (tight junction and adherens junction) that were significantly altered by the addition of β-mannanase. This is strong evidence for the efficacy of β-mannanase to reduce FIIR, as well as exert effects on metabolic functions not previously reported. Couple this with the results we observed in Figure 2 , that β-mannanase added to a diet containing βGAL clusters closer to groups without added βGAL, and the effect of the addition of β-mannanase to feed becomes clear. β-mannanase eliminated the FIIR induced by βGAL and resulted in a chicken gut that looks generally similar to a gut exposed to a normal diet containing β-mannanase.
The network diagrams in Figure 3 show the peptides that displayed uniquely altered phosphorylation in jejuna due to the addition of β-mannanase to the diet (regardless of dose). Conducting pathway analysis on these peptides did not generate any significant canonical pathways. However, as can be seen in Figure 3A , B, and C, the individual peptides are known to interact with each other, as evidenced by their interconnectedness in the diagrams. This is a novel interaction network not found in current databases and covers the consistent effects of B-mannanase. The lines connecting the peptides represent known protein-protein interactions (Szklarczyk et al., 2015) These could be considered "β-mannanase pathways," induced by the effect of β-mannanase in the gut. These interactions indicated that the changes in phosphorylation of these peptides were having a specific, interactive response. There was an increasing number of β-mannanase-impacted proteins as the birds increased in age, and this may be due to greater β-mannanase effects at a later age or a greater interaction with the finisher feed. The pathways are distinct between the different d either because the birds are older and their gut response is changing or the β-mannanase is interacting with the 3 broiler feed formulations-starter, grower, and finisher-provided at these time points. Table 3 is a list of proteins containing peptides that showed consistent differential phosphorylation in the jejuna of broiler chickens when fed β-mannanase. This phosphorylation is consistent across all 3 d post hatch, and all experimental conditions containing β-mannanase. Interestingly, all of these peptides were dephosphorylated relative to control fed birds. This list of proteins can be considered the biomarkers for β-mannanase activity in the jejuna of chickens. The proteins are involved in both metabolism and immunity, as shown in Table 2 , and β-mannanase has an effect on both of these physiological functions. Further study may allow us to manipulate this group of proteins to further enhance the anti-inflammatory (elimination of immune responses observed here), positive feed conversion (as observed in the companion paper by Latham et al.) , and gut health effects (tight junction effects shown here) observed with β-mannanase supplementation of broiler feed. At the very least, these proteins can be further studied as possible biomarkers of β-mannanase activity within the broiler gut.
This study has shown biologically relevant protein phosphorylation signal data confirming that βGAL induced a FIIR and that β-mannanase can eliminate that response, as has been postulated previously but not shown experimentally to date. In addition, β-mannanase has separate metabolic consequences besides the reduction in FIIR. β-mannanase may have positive effects in a diet formulation containing βGAL, as the kinotype of birds fed control diets containing β-mannanase is similar to those also fed βGAL and β-mannanase. Peptides are differentially phosphorylated due to β-mannanase at the 3 time points of this study, showing β-mannanase has age and/or feed formulation effect on the jejuna of chickens. These age-specific effects also can be considered time-dependent biomarkers of β-mannanase activity. This study has identified time-independent, dose-independent, and βGAL-independent markers of β-mannanase activity (Table 3) that may be used to monitor the activity and efficacy of β-mannanase-fed regimes in the future.
SUPPLEMENTARY DATA
Supplementary data are available at Poultry Science online. Table S1 : Peptide Phosphorylation Changes Unique to β-mannanase Addition at Day 14. 
